A piece of chewing gum may sound out of place in a cancer lab. Yet in this case, it became the delivery system for two ...

Deaths from rectal cancer are rising rapidly among younger adults, an alarming trend that is confounding scientists trying to ...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...

CatalYm today announced that the first patient has been dosed in the Phase 2/3 VINCIT trial (Visugromab IN Cachexia ...

Memorial Sloan Kettering scientists are shedding new light on a tumor’s earliest moments — revealing how lung cells with ...

Some of the earliest warning signs of breast cancer risk may be hidden deep within the molecular makeup of breast tissue—long ...

A new study suggests that a common pesticide, picloram, may contribute to growing rates of early onset colorectal cancer, asides from known risk factors such as smoking and diet.

Invenra, Inc., a biotechnology company pioneering multispecific antibody therapeutics, is requesting cancer patient and survivor artwork, which will be featured in an innovative project linking ...

An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Pressure on the heart as it pumps blood stops cancer cells from multiplying in mouse hearts. The beating of the heart stops ...